Paediatric functional abdominal pain disorders.

Nikhil Thapar, Marc A Benninga, Michael D Crowell, Carlo Di Lorenzo, Isabelle Mack, Samuel Nurko, Miguel Saps, Robert J Shulman, Hania Szajewska, Miranda A L van Tilburg, Paul Enck

Journal: Nature reviews. Disease primers 2021;6(1):89

PMID: 33154368

Abstract

Paediatric functional abdominal pain disorders, currently referred to as disorders of gut-brain interaction, comprise irritable bowel syndrome, functional dyspepsia, abdominal migraine and functional abdominal pain not otherwise specified, as defined by the Rome IV diagnostic criteria. Functional abdominal pain disorders are common disorders with a prevalence of 3-16% depending on country, age and sex. A greater understanding of aetiopathogenesis and pathophysiology is emerging and includes intestinal components (inflammation, motility and the microbiota), central factors (psychological aspects, sensitization and/or differences in connectivity or activity of certain brain regions) as well as extrinsic factors (infections). In particular, the timing of disruption of the microbiota-gut-brain axis seems to be important. Diagnosis is challenging but is primarily based on clinical symptoms and exclusion of other organic causes, with an emphasis on avoiding unnecessary invasive diagnostic procedures. The available pharmacological interventions are limited in children and, therefore, management has focused on combined approaches, including mind-targeted interventions (hypnotherapy and cognitive behavioural therapy), diet (probiotics) and percutaneous electrical nerve field stimulation. The evidence for their clinical efficacy, although limited, is favourable, with positive impacts on symptoms and overall quality of life. The coming decades hold promise for improved understanding and management of these enigmatic disorders.

Address: Neurogastroenterology and Motility Unit, Department of Paediatric Gastroenterology, Great Ormond Street Hospital NHS Foundation Trust, London, UK. [email protected].; UCL Great Ormond Street Institute of Child Health, London, UK. [email protected].; Queensland Children's Hospital, Paediatric Gastroenterology, Hepatology and Liver Transplant, Brisbane, Australia. [email protected].; Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, Netherlands.; Department of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, USA.; Division of Pediatric Gastroenterology, Nationwide Children's Hospital, Columbus, OH, USA.; University Hospital Tübingen, Department of Internal Medicine VI: Psychosomatic Medicine and Psychotherapy, Tübingen, Germany.; Boston Children's Hospital, Harvard medical School, Boston, MA, USA.; Division of Pediatric Gastroenterology, Hepatology and Nutrition, University of Miami, Miller School of Medicine, Miami, FL, USA.; Children's Nutrition Research Center, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.; Department of Pediatrics, The Medical University of Warsaw, Warsaw, Poland.; College of Pharmacy and Health Sciences, Campbell University, Buies Creek, NC, USA.; Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA.; School of Social Work, University of Washington, Seattle, WA, USA.; University Hospital Tübingen, Department of Internal Medicine VI: Psychosomatic Medicine and Psychotherapy, Tübingen, Germany. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.